Enasidenib Mesylate

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
(EH-nuh-SIH-deh-nib MEH-zih-layt)

This page contains brief information about enasidenib mesylate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Idhifa
FDA Approved
Yes

FDA Approval for Enasidenib Mesylate

Use in Cancer

Enasidenib mesylate is approved to treat:

Enasidenib mesylate is also being studied in the treatment of other types of cancer.

More About Enasidenib Mesylate

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Two New Therapies Approved for Acute Myeloid Leukemia

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Enasidenib Mesylate - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: August 8, 2017
  • Updated: September 29, 2017